COVID-19 IgM/IgG Lateral Flow Assay Sawirka

COVID-19 Baaritaanka socodka dambe ee IgM/IgG

COVID-19 IgG iyo IgM isku darka tijaabada degdega ah 10 daqiiqo gudahood

Walxaha la ogaado	SARS-CoV-2
Habka	Baaritaanka socodka dambe
Tusaalaha nooca	Dhiig dhan, Serum, Plasma
Tilmaamaha	20 tijaabo/xirmo
Koodhka badeecada	CoVMGLFA-01

Email noogu soo dir

Faahfaahinta Alaabta

Tags Product

Hordhac Product

Virusee® COVID-19 IgM/IgG Lateral Flow Assay waa immunoassay socodka lateral loo isticmaalo in vitro qualitative detection of novel coronavirus (SARS-CoV-2) IgM / IgG unugyada difaaca jirka ee ku jira venipuncture dhiiga oo dhan, balaasmaha, iyo shaybaarada serum.

Fayraska cusub ee coronavirus waa fayraska RNA-ga ee togan.Si ka duwan coronavirus kasta oo la yaqaan, dadka nugul ee Novel Coronavirus guud ahaan waa u nugul yihiin, waxayna aad khatar ugu tahay waayeelka ama dadka qaba cudurrada aasaasiga ah.Unugyada difaaca jirka ee IgM/IgG togan waa tilmaame muhiim u ah caabuqyada cusub ee coronavirus.Helitaanka unugyada cusub ee ka-hortagga coronavirus-ga ayaa caawin doona ogaanshaha bukaan-socodka.

Astaamaha

Magaca	COVID-19 Baaritaanka socodka dambe ee IgM/IgG
Habka	Baaritaanka socodka dambe
Tusaalaha nooca	Dhiiga, plasma, serum
Tilmaamid	20 tijaabo/xirmo
Waqtiga ogaanshaha	10 daqiiqo
Walxaha la ogaado	COVID-19
Xasilooni	Qalabku wuxuu xasilan yahay 1 sano oo ah 2-30 ° C

COVID-19 IgMIgG Baaritaanka socodka dambe

Faa'iidada

Degdeg ah
Ku hel natiijada 10 daqiiqo gudahood
Fudud
Natiijo akhris muuqaal ah, si fudud loo tarjumi karo
Habka fudud, oo aan qalliin adag lahayn

Kharash-keydinta
Alaabta waa la rari karaa laguna kaydin karaa heerkulka qolka, hoos u dhigista kharashyada
Khatar yar
Tijaabinta saamiga dhiigga, yaraynta khatarta habka muunada
Ku haboon baaritaanka goobta, sariirta, bukaan socodka

Asalkii hore iyo mabda'a

Fayraska novel coronavirus, cudurka daran ee neef-mareenka coronavirus (SARS-CoV) -2, ayaa loo aqoonsaday inuu yahay cudur-sidaha keena cudurka coronavirus 2019 (COVID-19).Cudurkan ayaa hay'adda caafimaadka adduunka ee WHO ugu yeertay xaalad degdeg ah oo caafimaad dadweyne.

COVID-19 waxa uu bartilmaameedsadaa hab-dhiska neef-mareenka sare iyo kan hoose oo waxa uu dadka badidood u keena calaamado u eg hargabka.In kasta oo bukaanno badan oo COVID-19 ah ay la kulmaan calaamado fudud, bukaannada qaarkood waxay leeyihiin calaamado daran oo u horseedaya dhaawac weyn oo sambabada ah.Ikhtiyaarada daawaynta ee COVID-19 waa xadidan yihiin waxaana heerka dhimashada cayriin ee WHO ay qiyaastay waa ku dhawaad 2.9%.In kasta oo tallaalka ka-hortagga ah ee COVID-19 uu ugu dambeyntii heli karo, haddii aan la helin difaac ku filan oo lo'da ah, COVID-19 wuxuu sababi karaa cudurro iyo dhimasho weyn sanadaha soo socda.

Ka dib marka aad la ildaran tahay infekshanka, waa wax caadi ah in la sameeyo jawaab celin liddi ku ah cudur-sidaha gaarka ah.Goor hore ka dib caabuqa (badanaa ka dib usbuuca ugu horeeya), waxa soo baxa nooc ka mid ah unugyada difaaca jirka ee loo yaqaan immunoglobulin M (IgM), inkasta oo kuwani aanay caadi ahaan wakhti dheer soconayn.Ka dib, 2-4 toddobaad ee ugu horreeya ka dib caabuqa, IgG, oo ah antibody aad u waara, ayaa la soo saaraa.

Daraasaduhu waxay ogaadeen in unugyada difaaca jirka ee RBD ay yihiin calaamado aad u wanaagsan oo hore iyo kuwa dhowba, in cabbirada isotype ee kala duwani ay ka caawin karaan kala soocidda caabuqyada dhawaan iyo kuwii hore.Ogaanshaha unugyada difaaca jirka ee IgM iyo IgG ee ka dhanka ah SARS-CoV-2 waxay leedahay muhiimad suurtagal ah oo lagu qiimeeyo darnaanta iyo saadaalinta COVID-19, iyo xitaa kordhinta saxnaanta ogaanshaha tijaabada aashitada nukliyeerka.

Ogaanshaha SARS-CoV-2 IgM iyo IgG aad ayey muhiim u tahay in la go'aamiyo koorsada COVID-19.Ogaanshaha Nucleic acid oo ay weheliso serum antibody ee SARS-CoV-2 waxay noqon kartaa tilmaame shaybaadhka ugu fiican ee ogaanshaha infekshanka SARS-CoV-2 iyo weedha iyo saadaalinta saadaalinta COVID-19.